First Insights into the Molecular Basis of Pleomorphic Adenomas of the Salivary Glands

Abstract

Pleomorphic adenoma, or mixed tumor of the salivary glands, is a benign tumor originating from the major and minor salivary glands. Eighty-five percent of these tumors are found in the parotid gland, 10% in the minor (sublingual) salivary glands, and 5% in the submandibular gland. It is the most common type of salivary gland tumor, accounting for almost 50% of all neoplasms in these organs. In fact, after the first observation of recurrent loss of chromosome 22 in meningioma, this was the second type of benign tumor for which non-random chromosomal changes were reported. The rate of malignant change with the potential to metastasize has been reported to be only 2 to 3%, and only a few cases of metastasizing pleomorphic salivary gland adenomas have been described to date. The fact that these tumors arise in organs located in an ontogenetic transitional zone, a region where endoderm and ectoderm meet, might be one of the reasons for the often-problematic histopathological classification. This type of benign tumor has been cytogenetically very well-characterized, with several hundreds of tumors karyotyped. In addition to the cytogenetic subgroup with an apparently normal diploid stemline (making up approximately 30% of the cases), three major cytogenetic subgroups can be distinguished. In addition to a subgroup showing non-recurrent clonal abnormalities, another subgroup is composed of tumors with various translocations involving 12ql5. By far the largest cytogenetic subgroup, however, consists of tumors with chromosome 8 abnormalities, mainly showing translocations involving region 8ql2. The most frequently encountered aberration in this group is a t(3;8)(p21;q12).

Keywords

PLAG I gene IGF-II pleomorphic adenoma salivary gland zinc finger.

Get full access to this article

View all access options for this article.

References

Astrom AK , Voz ML , Kas K. , Roijer E. , Wedell B. , Mandahl N. , et al. (1999). Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res 59:918-23.

Cavin Perier R. , Junier T. , Bucher P. (1998). The eukaryotic promoter database EPD. Nucleic Acids Res 26:353-357.

Choo Y. , Klug A. ( 1994). Selection of DNA binding sites for zinc fingers using rationally randomized DNA reveals coded interactions. Proc Natl Acad Sci USA 91:11168-11172.

Gearing DP , Thut CJ , VandenBos T. , Gimpel SD , Delaney PB , King J. , et al. (1991). Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gpl30. EMBO J 10:2839-2848.

Gearing DP , Druck T. , Huebner K. , Overhauser J. , Gilbert DJ , Copeland NG , et al. (1993). The leukemia inhibitory factor receptor (LIFR) gene is located within a cluster of cytokine receptor loci on mouse chromosome 15 and human chromosome 5pl2-pl3. Genomics 18:148-150.

Haber DA , Buckler AJ , Glaser T. , Call KM , Pelletier J. , Sohn RL , et al. (1990). An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61:1257-1269.

Kas K. , Voz ML , Roijer E. , Astrom AK , Meyen E. , Stenman G. , et al. (1997). Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat Genet 15:170-174.

Kas K. , Voz ML , Hensen K. , Meyen E. , Van de Ven WJM (1998). Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. J Biol Chem 273:23026-23032.

Kerckaert JP , Deweindt C. , Tilly H. , Quief S. , Lecocq G. , Bastard C. (1993). LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 5:66-70.

10.

Kraus C. , Liehr T. , Hulsken J. , Behrens J. , Birchmeier W. , Grzeschik KH , et al. (1994). Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics 23:272-274.

11.

Nollet F. , Berx G. , Molemans F. , van Roy F. (1996). Genomic organization of the human beta-catenin gene (CTNNB1). Genomics 32:413-424.

12.

Park H. , Baek K. , Jeon C. , Agarwal K. , Yoo O. (1994). Characterization of the gene encoding the human transcriptional elongation factor TFIIS. Gene 139:263-267.

13.

Roijer E. , Kas K. , Klawitz I. , Bullerdiek J. , Van de Ven W. , Stenman G. (1996). Identification of a yeast artificial chromosome spanning the 8q12 translocation breakpoint in pleomorphic adenomas with t(3;8)(p21;q12) . Genes Chromosomes Cancer 17:166-171.

14.

Toretsky JA , Helman LJ (1996). Involvement of IGF-II in human cancer. J Endocrinol 149:367-372.

15.

Voz ML , Astrom AK , Kas K. , Mark J. , Stenman G. , Van de Ven WJ (1998). The recurrent translocation t(5;8)(pl3;ql2) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter. Oncogene 16:1409-1416.

16.

Willert K. , Nusse R. (1998). Beta-catenin: a key mediator of Wnt signaling . Curr Opin Genet Dev 8:95-102.